Two Sisters Commits to Responsible use of Antibiotics

Two Sisters Commits to Responsible use of Antibiotics

UK – Poultry meat company, 2 Sisters, is
making moves to preserve the effectiveness
of antibiotics critical to human health. It is to
remove antibiotics used in medicine from its
poultry production and setting up two trial
farms to identify techniques to reduce overall antibiotic use in future. 2 Sisters Food Group has committed to
removing from their poultry production all
antibiotics defined by the World Health
Organisation (WHO) as being of highest
priority critically important to human health.
This move will help preserve the effectiveness of antibiotic use for people. Antibiotics are used in poultry production to
treat and prevent infectious diseases and
safeguard poultry health and welfare. There is
a risk that antibiotic use in animal agriculture
contributes to the emergence of antibiotic-
resistant bacteria, which can spread to humans and make standard treatments of
infectious diseases ineffective. For the past two years, 2 Sisters Food Group
has not used three of the antibiotic classes the
WHO identified as highest priority critically
important to human medicine – the third and
fourth generation cephalosporins or
fluroquinolones. The announcement also excludes the antibiotic
class macrolides from all of its broiler
production. 2 Sisters Food Group also announced that it
will establish two trial farms, fully supervised
by company veterinary surgeons and
independent agricultural experts. The farms will spearhead practical research to
help develop and roll out on-farm techniques,
and health and management practices that will
reduce the industry’s need for antibiotics in
the future. Ranjit Singh, CEO of 2 Sisters Food Group, said:
“As a responsible and forward thinking
organisation, we are keen to lead on this
increasingly important issue and take a stand
which we feel is pragmatic and sensible. “We are committed to ensure that we use all
medicines, including antibiotics, in a
responsible manner across the farms that
supply us, and lead the industry in delivering a
strategy which protects both animal and
human interests, now and in the future.” In drawing up the new policy, the business
has reviewed expert opinion from the World
Health Organisation (WHO), the World
Organisation for Animal Health (OIE) and The
European Medicines Authority (EMA) and
worked with the Food Animal Initiative (FAI). Michelle Waterman, 2 Sisters’ Group Agriculture
Director, added: “Our plan is also about
replacing antibiotic use with other
interventions wherever possible. This includes
use of vaccinations and changes to husbandry
and biosecurity techniques. Our strategy is continually refined through the use of trial
locations to see what works best.” Ruth Layton, Director of FAI, said: “The
programme of work we are undertaking with
2 Sisters Food Group approaches the human
health challenge of emerging antimicrobial
resistance with the thoughtful, urgent and
practical actions it requires. “These steps show how our ‘replace, reduce,
refine’ framework, adopted to great effect in
other sectors, can guide company behavior
that will safeguard human and animal health,
while protecting the efficacy of lifesaving
antibiotics.”

Categories: Press Release

Write a Comment

Your e-mail address will not be published.
Required fields are marked*